Pharmaceutical companies historically have been therapeutically oriented with teams isolated from each other, working on one disease or one product. Some of the technology changes that promised to revolutionize the development process have resulted in improvements in high-performing organizations, but have done little to streamline much of the management of clinical trials. There has still been little cross-fertilization between teams. Now, they need to adopt a culture and merge the best practices of the multiple therapeutic entities for flawless execution in both resource utilization and clinical trial conduct.

 

Challenges arise in the identification of the right people at the ideal time in the project, utilization of efficient systems to manage the information they need to assess progress, development of simple processes tailored within the framework of the organization's Standard Operating Procedures, and the provision of supplies required to execute the program.

 

These elements are the true foundations of a clinical development operations department. They cannot be diverted from their goal to focus on creating, developing, assembling, hiring or training to continue forward.

 

Halloran has guided numerous companies to establish Clinical Development Operations (ClinOps), enabling their management to add focus to the centralized supportive roles that add value and efficiency.